MRI Helps Identify and Treat Irritable Bowel Syndrome
By MedImaging International staff writers Posted on 20 Jan 2014 |
British scientists are utilizing magnetic resonance imaging (MRI) technology to assist in the treatment and diagnosis of irritable bowel syndrome (IBS), a disorder that causes serious discomfort and distress to sufferers.
In three separate studies, researchers examined the disorder and found another way of examining the condition, which could have major implications in how it is both diagnosed and treated in the future.
The three studies explored the effectiveness of using MRI to evaluate the colon, which has a number of novel advantages. Before this, clinicians have relied on -rays to view the colon, which has limitations due to the risks tied to radiation. By using MRI as an alternative, the researchers have been able to image the bowel continuously with no risk to the patient, enabling them to learn more about the inner workings of the gut.
The research has been led by researchers from the University of Nottingham’s (UK) Digestive Diseases Center (NDDC) and scientists from the Sir Peter Mansfield Magnetic Resonance Center at the University. In the first study, published in the January 2014 issue of the journal Neurogastroenterology and Motility, scientists were able to image the colon and split it in to three functional regions: the ascending colon, which is a storage and fermentation region, where unabsorbed residue is broken down by bacteria; the transverse colon, which is a storage area for the residue left after bacterial processing, and the descending colon, which is an organ that pushes waste down and out of the body.
Using MRI, scientists can also measure the volumes of these regions, which they have never been able to do before. Prof. Robin Spiller, lead director of Nottingham digestive diseases biomedical research unit, said, “We studied people with accelerated transit and to our surprise, we found that the colon size was rather similar to those with normal transit suggesting people regulate their bowel habit to keep the colonic size constant. We also know that when you eat a meal the ascending colon expands as the meal is pushed down into it to make space in the small bowel for the new meal. We found that this increase was smaller in IBS patients than in healthy volunteers, suggesting that the IBS patient’s ascending colon can’t relax enough. With MRI, we can actually measure this change in a way that we’ve never been able to do before. This will have other benefits in the future, for instance we will be able to measure the effect of some drugs on the bowel.”
In the second study, published in the January 2014 issue of the journal Neurogastroenterology and Motility, scientists used MRI scanning to gauge the actual time it takes for contents to transit the bowel, using specially designed MRI visible markers, which subjects ingest. Scientists can then image the bowel 24 hours later to see how far they have moved. Previously, motility had to be measured using X-rays, which has extremely limited the circumstances when the measurement could be made.
In the third study, published online November 19, 2013, in American Journal of Gastroenterology, researchers used the colonic imaging technique again, but this time, to improve their understanding of the causes of IBS. By looking at fructose, a sugar commonly found in fruit, and fructans, which are polymers of fructose, researchers were able see what effects these had on the gut of healthy study participants. “We already know that fructose is difficult to absorb, but the novelty with this new method, is that we are now able to image the end effect of this malabsorption which is the distension of the small intestine and colon. We are currently repeating these studies in patients with IBS to see whether their symptoms correlate with the distension of the colon.”
Fructans and fructose are part of a group of chemicals called FODMAPs (fermentable oligo, di- monosaccharides and polyhydric) alcohols, whose characteristics are that they are comparatively tough to absorb, but they are fermentable, so when they go in to the colon they are exposed to the bacteria and produce gas.
Prof. Spiller continued, “It’s been found that diets that restrict the intake of these things improve symptoms and our MRI studies show us scientifically why that improvement might occur. We were able to show that while fructose alone was poorly absorbed and distended the small bowel, when it was combined with glucose the poor absorption was prevented. We also found that fructans have little effect in the small bowel but a large effect on the colon. In future, will be able to use our MRI techniques to test specific foods to understand how they will affect IBS.
“By defining the link between the chemistry of food to its impact on the bowel our technique will enable us to answer specific questions, e.g., when an apple ripens and the sugar content rise, does the adverse effect reduce? This might explain why green apples can cause stomachache while ripe ones do not. The fructose in the green apple is malabsorbed but as it ripens the glucose content rises improves fructose absorption, improving the rate of absorption.”
Related Links:
University of Nottingham
In three separate studies, researchers examined the disorder and found another way of examining the condition, which could have major implications in how it is both diagnosed and treated in the future.
The three studies explored the effectiveness of using MRI to evaluate the colon, which has a number of novel advantages. Before this, clinicians have relied on -rays to view the colon, which has limitations due to the risks tied to radiation. By using MRI as an alternative, the researchers have been able to image the bowel continuously with no risk to the patient, enabling them to learn more about the inner workings of the gut.
The research has been led by researchers from the University of Nottingham’s (UK) Digestive Diseases Center (NDDC) and scientists from the Sir Peter Mansfield Magnetic Resonance Center at the University. In the first study, published in the January 2014 issue of the journal Neurogastroenterology and Motility, scientists were able to image the colon and split it in to three functional regions: the ascending colon, which is a storage and fermentation region, where unabsorbed residue is broken down by bacteria; the transverse colon, which is a storage area for the residue left after bacterial processing, and the descending colon, which is an organ that pushes waste down and out of the body.
Using MRI, scientists can also measure the volumes of these regions, which they have never been able to do before. Prof. Robin Spiller, lead director of Nottingham digestive diseases biomedical research unit, said, “We studied people with accelerated transit and to our surprise, we found that the colon size was rather similar to those with normal transit suggesting people regulate their bowel habit to keep the colonic size constant. We also know that when you eat a meal the ascending colon expands as the meal is pushed down into it to make space in the small bowel for the new meal. We found that this increase was smaller in IBS patients than in healthy volunteers, suggesting that the IBS patient’s ascending colon can’t relax enough. With MRI, we can actually measure this change in a way that we’ve never been able to do before. This will have other benefits in the future, for instance we will be able to measure the effect of some drugs on the bowel.”
In the second study, published in the January 2014 issue of the journal Neurogastroenterology and Motility, scientists used MRI scanning to gauge the actual time it takes for contents to transit the bowel, using specially designed MRI visible markers, which subjects ingest. Scientists can then image the bowel 24 hours later to see how far they have moved. Previously, motility had to be measured using X-rays, which has extremely limited the circumstances when the measurement could be made.
In the third study, published online November 19, 2013, in American Journal of Gastroenterology, researchers used the colonic imaging technique again, but this time, to improve their understanding of the causes of IBS. By looking at fructose, a sugar commonly found in fruit, and fructans, which are polymers of fructose, researchers were able see what effects these had on the gut of healthy study participants. “We already know that fructose is difficult to absorb, but the novelty with this new method, is that we are now able to image the end effect of this malabsorption which is the distension of the small intestine and colon. We are currently repeating these studies in patients with IBS to see whether their symptoms correlate with the distension of the colon.”
Fructans and fructose are part of a group of chemicals called FODMAPs (fermentable oligo, di- monosaccharides and polyhydric) alcohols, whose characteristics are that they are comparatively tough to absorb, but they are fermentable, so when they go in to the colon they are exposed to the bacteria and produce gas.
Prof. Spiller continued, “It’s been found that diets that restrict the intake of these things improve symptoms and our MRI studies show us scientifically why that improvement might occur. We were able to show that while fructose alone was poorly absorbed and distended the small bowel, when it was combined with glucose the poor absorption was prevented. We also found that fructans have little effect in the small bowel but a large effect on the colon. In future, will be able to use our MRI techniques to test specific foods to understand how they will affect IBS.
“By defining the link between the chemistry of food to its impact on the bowel our technique will enable us to answer specific questions, e.g., when an apple ripens and the sugar content rise, does the adverse effect reduce? This might explain why green apples can cause stomachache while ripe ones do not. The fructose in the green apple is malabsorbed but as it ripens the glucose content rises improves fructose absorption, improving the rate of absorption.”
Related Links:
University of Nottingham
Latest MRI News
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
- New Model Makes MRI More Accurate and Reliable
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more